Evaluation of hematologic profile may be needed for patients treated with oxcarbazepine
Gu Hyun Jung, Su Jeong You
Clin Exp Pediatr. 2019;62(8):312-316. Published online 2019 Apr 11 DOI: https://doi.org/10.3345/kjp.2019.00017
Citations to this article as recorded by
Why should we monitor for hematologic adverse drug reactions to oxcarbazepine?
Gwang Cheon Jang
Korean Journal of Pediatrics.2019; 62(8): 299. CrossRef
Reactions Weekly.2019; 1772(1): 260. CrossRef